Benefits versus risks from mammography: A critical reasessment

Cancer

Volumn 77, Issue 5, 1996, Pages 903-909

  Mettler, Fred A ^a   Upton, Arthur C ^a   Kelsey, Charles A ^a   Ashby, Robert N ^a   Rosenberg, Robert D ^a   Linver, Michael N ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Breast cancer; Mammography; Radiation dosage; Radiation risk

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; RISK ASSESSMENT;

EID: 0030059775     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960301)77:5<903::AID-CNCR15>3.0.CO;2-7     Document Type: Article

References (49)

1. Mettler FA, Hampelmann L, Dutton A, Pifer JW, Toyooka ET, Ames WR. Breast neoplasms in women treated with x-rays for acute post-partum mastitis. J Natl Cancer Inst 1969:43:803-11.
2. Thompson D, Mabuchi K, Ron E, Tokumaga M, Ochikubo S, Sugimoto S, et al. Cancer incidence in atomic bomb survivors, Part II, solid tumors 1958-1987. Radiat Res 1964; 137:517-67.
3. Tokunaga M, Land C, Tukapka S, Nishimori I, Soda M, Akiba S. Incidence of female breast cancer in atomic bomb survivors, 1950-1985. Radiat Res 1994; 138:209-23.
4. Tokunaga M, Land C, Aoki Y, Yamamoto T, Asano M, Sato E, et al. Proliferative and non-proliferative breast disease in atomic bomb survivors. Cancer 1993:72:1657-65.
5. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B. Breast cancer among women given x-ray therapy for portpartum masticis. J Natl Cancer Inst 1986:77:689-96.
6. Beral E, Larsson LE, Mattson B. Breast cancer following irradiation of the breast. Cancer 1977; 40:2905-10.
7. Mattson A, Ruden B, Hall P, Wilking N, Rutqvist LE. Radiation-induced breast cancer: long-term follow-up of radiation therapy for breast disease. J Natl Cancer Inst 1993;85:1679-85.
8. Darby SC, Doll R, Gill S, Smith PG. Long-term mortality after a single treatment course with x-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987:55:179-90.
9. Furst C, Lundell M, Holm LE. Tumors after radiotherapy for skin hemangioma in childhood: a case-control study. Acta Oncol 1990:29:557-62.
10. Ron E, Modan B, Boice JD Jr. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol 1988; 127:713-25.
11. Hildreth N, Shore RE, Dvoretsky P. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989:321:1281-4.
12. Hancock S, Tucker M, Hoppe R. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993:85:25-31.
13. Li FP, Corkery J, Vawter G, Fine W, Sallan SE. Breast carcinoma after cancer therapy in childhood. Cancer 1983; 51:521-3.
14. Hrubec Z, Boice JD Jr, Monson R, Rosenstein M. Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. Radiat Res 1989:49:229-34.
15. Miller AB, Howe GR, Sherman GJ, Lindsay BA, Martin JY, Dinner PJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Eng J Med 1989;321:1285-9.
16. Huffman D, Lonstein J, Morin M, Visscher W, Harris BSH III, Boice JD Jr. Breast cancer in women with scoliosis exposed to multiple diagnostic x-rays. J Natl Cancer lnst 1989:81:1307-12.
17. Adams E, Brues A. Breast cancer in female radium dial workers first employed before 1930- J Occup Med 1980;22:583-7.
18. Stebbings J, Lucas H, Stehney A. Mortality from cancers of major sites in female radium dial. Am J Ind Med 1984;5:435-59.
19. Machado S, Land C, McKay F. Cancer mortality rates and radioactive fallout in southwestern Utah. Am J Epidemiol 1987; 125:44-61.
20. Wiklund K, Holm LE, Eklund G. Cancer risk in Swedish Lapps who breed reindeer. Am J Epidemiol 1990; 132:1078-82.
21. Jablon S, Hrubec Z. Boice JD Jr, Stone BJ. Cancer in populations living near nuclear facilities. Bethesda (MD): National Cancer Institute; 1990. NIH Pub. No. 90-874.
22. Beral V, Fraser P, Carpenter L, Booth M, Brown A, Rose G. Mortality of employees of the atomic weapons establishment 1951-1982. BMJ 1988;297:757-70.
23. Gilbert E, Cragle D, Wiggs L. Updated analysis of combined mortality data at the Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Weapons Plant. Radiat Res 1993:136:408-21.
24. Holm LE, Wiklund KE, Lundel GE, Bergman NÅ, Bjelkengren G, Ericcson UC, et al. Cancer risk in population examined with diagnostic doses of iodinc-131- J Natl Cancer lnst 1989:81:302-6.
25. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. Annex C, Medical Radiation Exposures. 1993 Report to the General Assembly. 1993 Vienna, Austria.
26. Land CE, Boice JD Jr, Shore R, Norman JE, Tokunaga M. Breast risk from low-dose exposures to ionizing radiation: results of an analysis in parallel of data from three different exposed populations. J Natl Cancer lnst 1980:65:353-76.
27. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Epidemiological studies of radiation carcinogenesis. Report to the General Assembly. 1994 Vienna, Austria.
28. Boice JD Jr, Land CE, Shore R, Norman JE, Tokunaga M. Risk of breast cancer following low-dose radiation exposure. Radiology 1979; 131:589-97.
29. National Academy of Sciences/National Research Council. Health effects of exposure to low levels of ionizing radiation. BEIR V. Washington, DC: National Academy Press, 1990.
30. Shapiro S. Screening: assessment of current studies. Cancer 1994; 74(Suppl):231-8.
31. Kopans D. Questions and answers. AJR Am J Roentgenol 1994:163:1524.
32. Kerlikowske K, Grady D, Rubin S, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995:273:149-54.
33. Smart C, Hendrick R, Rutledge J, Smith R. Benefit of mammography screening in women aged 40-49: current evidence from randomized screening trials. Cancer. In press.
34. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. AJR Am J Roentgenol 1993:161:755-60.
35. Burhenne LJW, Burhenne HJ. The Canadian National Breast Screening Study: a Canadian critique. AJR Am J Roentgenol 1993;161:761-3.
36. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ. A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 1993; 189:661-3.
37. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995;75(4):997-1003.
38. SEER. Cancer statistics review, 1973-1990. Bethesda (MD): National Cancer Institute; 1993 NlH Pub. No. 93-2789.
39. Tabar L, Fagerberg G, Chen H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75(10):2507-17.
40. Feig SA. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years. Cancer 1995;75(10):2412-19.
41. Land C. Breast cancer in the RERF Life Span Study. RERF Update, Spring Newsletter, 1993: 3-4. Hiroshima, Japan: Radiation Effects Research Foundation, 1993.
42. Land C, Hayakawa N, Machado S, Yamada Y. A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose. Cancer Causes Control 1994;5(2):167-76.
43. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991;325:1831-6.
44. Boice J Jr, Miller R. Risk of breast cancer in ataxia-telangiectasia [letter to the editor]. N Engl J Med 1992;326(20):1357-8.
45. Bridges BA, Arlett CF. Risk of breast cancer in ataxia-telangiectasia [letter to the editor]. N Engl J Med 1992;326(20):1357-8.
46. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. Isolation of BRACl, the 17q-linked breast and ovarian cancer susceptibility gene. Science 1994:266:66-71.
47. Wooster R, Neuhausen S, Mangion Y, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRAC2, to chromosome 13q 12-13. Science 1994; 265:2088-90.
48. Easton DF, Bishop D, Ford D. Crockford G. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993:52:678-701.
49. Nowak R. Breast cancer gene offers surprises. Science 1994:265:1796-99.